Scientists Develop Gene Therapy to Reprogram Pancreas for Continuous GLP-1 Production
Scientists develop a gene therapy to make the pancreas produce continuous GLP-1, offering a potential single-dose alternative to drugs like Ozempic. Read the full analysis.